Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients
Status:
Unknown status
Trial end date:
2019-04-24
Target enrollment:
Participant gender:
Summary
This study makes an observation over the objective response rate of Apatinib and 5-Fu
combination regimen in the three-line treatment of metastatic colorectal cancer. All the
participants will randomly receive the treatment of Apatinib and 5-Fu combination regimen or
5-Fu.